Melanoma May No Longer Be a Death Sentence

June 3 (Bloomberg) -- The next generation of experimental immune-boosting drugs from Merck, Bristol-Myers and Roche are producing such promising early results that doctors are openly speculating that some patients with the deadliest form of skin cancer may be cured. Olivia Sterns reports on Bloomberg Television's "Street Smart." (Source: Bloomberg)
Former CEO of PT Berau Refuses to Leave His Office
04:48 - There are new twists in the tale of Indonesian coal miner Berau with a former director refusing to leave his position or his office. At the same time, shares of its parent company, Asia Resource Minerals, have been suspended in London. Bloomberg’s Haslinda Amin reports on “Trending Business.” (Source: Bloomberg)
  • The Top Stocks to Watch in Asia Today
  • Japanese Market Is Showing Signs of Life: Dagan
  • Hanergy's Li Increased Short Position Before Stock Crash